Three quarters of people on Victoza lost more than five per cent of their body weight, compared with less than half than orlistat and less than a third who were given a placebo.
The jab, given once daily works by intensifying the 'full' feeling patients get after eating, and by reducing the speed at which their stomach empties.
The manufacturers may need to apply for a new licence for Victoza to be used solely for obesity, however the majority of cases of type 2 diabetes are linked to being overweight.
VICTOZA had been launched in Europe this past summer, but we wait for a deadlocked FDA Advisory Panel to make some move on this highly anticipated drug.
Yes, they do refer to an injection as a "jab" in the United Kingdom.
The full article ishere.